Legal Guidance and Research / Experts / Louise Fullwood
Louise Fullwood#10668

Louise Fullwood

Louise advises on healthcare regulatory, commercial, intellectual property and technology matters for a range of clients. Louise worked in cardiovascular research at Nottingham University Hospital prior to her legal career and spent 4 years as a non-executive director of NHS Blood & Transplant, and hence brings an understanding of healthcare in practice to ensure that advice provided to clients is not simply legally correct and commercially robust but is also framed within the wider context of regulatory requirements and ethical sensitivities. Her areas of expertise include due diligence assessments of regulatory compliance; interacting with regulatory bodies; drafting and negotiating agreements for the provision of regulated activities and advising on strategy for organisations looking to enter the market or extend into new activities. Louise also teaches on the UCL Transactional Intellectual Property course and is a co-lead on an EU Innovative Medicines Initiative research programme on use of Big Data to improve prostate cancer outcomes.

Practice Area

Panel

  • Contributing Author

Qualified Year

  • 1997

Experience

  • Pinsent Masons (1997 - 2023)
  • Nottingham University Hospital (1987 - 1995)

Qualifications

  • Legal Practice Course (1995)
  • Post-graduate Diploma in Law (1994)
  • BA(Hons) Physiology (1993)

Education

  • Nottingham Law School (1993 - 1995)
  • Open University (1987 - 1993)

1 Contributions by Louise Fullwood

England Healthcare Regulatory Framework: DHSC and arm’s length bodies; NHS England/NHS Improvement licensing; CQC regulated activities; PSA oversight; other regulators; transitional reforms
PRACTICE NOTES
England Healthcare Regulatory Framework: DHSC and arm’s length bodies; NHS England/NHS Improvement licensing; CQC regulated activities; PSA oversight; other regulators; transitional reforms
Practice Note A UK healthcare provider may fall under the oversight of multiple regulators and must adhere to their requirements. This Practice Note offers a concise outline of those authorities, acknowledging that the regulatory landscape is in transition: NHS England is being brought more closely within the control of the Department of Health and Social Care (DHSC) and is to be fully integrated by 2027; the number of Integrated Care Boards will reduce from 42 separate organisations to 27 clusters; reform of the Care Quality Commission (CQC) is under way following the recent Dash and Richardson reports. It should be remembered that healthcare across the UK is devolved to four administrations—England, Northern Ireland, Scotland and Wales—with regulatory variation between them. While there are shared foundations, material differences remain, and this summary addresses the position in England only. It focuses on healthcare as a service, not on the regulation of medicinal products or medical devices, and does not directly cover care or care-adjacent services such as children’s homes...
Local Government
Expert page AD
If you expected to see yourself on this page, click here.